Armetheon Obtains $7,000,000 Series A Funding

  • Feed Type
  • Date
    8/29/2014
  • Company Name
    Armetheon
  • Mailing Address
    325 Sharon Park Drive Menlo Park, CA 94025 USA
  • Company Description
    Armetheon, Inc., is a privately held San Francisco Bay area based clinical stage biopharmaceutical company focused on the development of novel drugs for highly unmet need in cardiovascular diseases. The company was founded by three successful biotech entrepreneurs and pharmaceutical executives with several years of drug R&D and company building experience.
  • Website
    http://www.armetheon.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funds will be used to keep to our NDA filing timeline in 2017 for Tecarfarin.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

By posting a comment, you agree to our terms and conditions.